DTE
38
-4
KMB
31
-11
AON
62
-5
MLM
67
4
MTCH
59
9
AIV
37
-2
AEP
61
-3
NWS
60
2
MS
74
5
CCI
36
2
OXY
40
2
MTB
73
4
TDC
70
3
VZ
35
-2
UNP
38
2
INTC
43
6
TEL
66
6
T
23
2
ZION
71
2
AZO
42
-3
DTE
38
-4
KMB
31
-11
AON
62
-5
MLM
67
4
MTCH
59
9
AIV
37
-2
AEP
61
-3
NWS
60
2
MS
74
5
CCI
36
2
OXY
40
2
MTB
73
4
TDC
70
3
VZ
35
-2
UNP
38
2
INTC
43
6
TEL
66
6
T
23
2
ZION
71
2
AZO
42
-3
Financhill
Back

Vanguard Short-Term Tax-Exempt Bond ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
48

VTES
Vanguard Short-Term Tax-Exempt Bond ETF

Last Price:
$101.60
Seasonality Move:
1.31%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Sell
48
Vanguard Short-Term Tax-Exempt Bond ETF (VTES) is a Sell

Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.59. The Score for VTES is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VTES Stock Price Chart

What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?

  • The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

VTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 19.1 Buy
Relative Strength Index (14 RSI): 55.82 Buy
Chaikin Money Flow: 100142 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.43 - 101.59) Buy
Bollinger Bands (100): (101.41 - 101.89) Sell

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

VTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.54 Buy
20-day SMA: 101.52 Buy
50-day SMA: 101.55 Buy
200-day SMA: 101.04 Buy
8-day EMA: 53.79 Buy
20-day EMA: 26.35 Buy
50-day EMA: 11.49 Buy
200-day EMA: 3 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):